Hib


Also found in: Dictionary, Thesaurus, Medical, Acronyms, Wikipedia.

Hib

Haemophilus influenzae type b: a vaccine against a type of bacterial meningitis, administered to children
References in periodicals archive ?
Takeda proposed alternatives to GSK to allow the launch of VAXEM Hib to proceed as planned, but GSK deemed these options not feasible.
The Hib response after the fourth dose also was demonstrated to be noninferior to HibPRP-OMP (the percentage of subjects with anti-HibPRP antibody concentrations [greater than or equal to] 1.
Amerika Birlesik Devletleri'nde (ABD) 1988 yilinda konjuge Hib asisinin kullanima girmesiyle, 1995'ten itibaren invaziv Hib enfeksiyonlarinda %95-99 oraninda azalma gerceklesmis ve bes yas altinda invaziv Hib enfeksiyonu sikligi 1/100 000'den az gorulmeye baslanmistir.
This approval will provide an additional safe and effective vaccine to help ensure that there is an adequate Hib vaccine supply during necessary catch-up vaccinations," Dr.
Since the campaign, there has been an increase in the number of Hib cases among one- to three-year old children, primarily in children too young to be vaccinated during the booster campaign.
The Centers for Disease Control and Prevention, the national Advisory Committee on Immunization Practices and other partners are continuing to monitor the supply of available Hib vaccines and any reports of Hib infection.
Several studies (2) have shown that introducing Hib vaccines in developing countries can result in a reduction of invasive Hib disease rates by over 80%.
Hib immune response induced by the Hib-MenCY-TT combination vaccine was non-inferior and statistically significantly higher than the monovalent Hib vaccine (93.
Most, but not all (2), DTaP-Hib vaccines result in lower Hib antibody concentrations shortly after vaccination when compared with DTwP-Hib vaccines (3), but the persistence of this effect has not been studied and its clinical significance is controversial (3).
Researchers don't know how to account for the geographic variation of vaccine-induced Hib immunity in the United States.
Fitch would expect to resolve the Rating Watch Positive in the first quarter of 2006 following additional results for both COF and HIB.
The children in these studies received various Hib conjugate vaccines for the primary series, including Hiberix (not approved for primary series in the United States), and the monovalent Hib vaccines currently licensed for primary series in the United States, ActHIB (PRP-T, Sanofi Pasteur, Swiftwater, Pennsylvania) and PedvaxHIB (PRP-OMP, Merck & Co.